Search
Polymer Factory Sweden (publ) Interim report Q3 2025
Third quarter, July-September 2025 Polymer Factory completes strategic delivery to Leading Biopharmaceutical Company based in Boston area Dendritic nanogels (DNGs) based on Polymer Factory’s proprietary bis-MPA dendritic nanotechnology show promise as nanocarrier against aggressive tumors Polymer Factory Granted SpheriCal Patent and Dendritic Nanogel (DNG) Patent in Multiple European Countries Polymer Factory Receives Approx. SEK 2.05 Million Through 100% Exercise of Warrant
Change of Management in Polymer Factory Sweden AB (publ)
Polymer Factory Sweden AB (publ) today announced that CEO Elin Mignérus and the Company’s Board of Directors have mutually agreed to part...
Polymer Factory Receives Approx. SEK 2.05 Million Through 100% Exercise of Warrants of Series TO1
Polymer Factory Sweden AB (“Polymer Factory” or the “Company”) today announces that all 2,737,772 outstanding warrants of series TO1 have...